4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-025115
President and CEO sold 18,334 shares at an average $56.60 ($1,037,684)
- President and CEO gave 40,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-03-09 | Gift | −40,000 | 2,265,742 | I | ||
| Watts Ryan J. President and CEO | 2021-04-01 | Sale | −5,232 | $55.52 | $290,486 | 2,260,510 | I |
| Watts Ryan J. President and CEO | 2021-04-01 | Sale | −8,516 | $56.88 | $484,356 | 2,251,994 | I |
| Watts Ryan J. President and CEO | 2021-04-01 | Sale | −4,586 | $57.31 | $262,842 | 2,247,408 | I |
| Open-market sales · 18,334 sh · avg $56.60 · $1,037,684 | |||||||
Loading xslF345X03/doc4.xml…